News | July 24, 2007

Siemens Expands Presence in Diagnostics Market Through Dade Behring Acquisition

July 25, 2007-Siemens has agreed to acquire all outstanding shares of Dade Behring by submitting a cash offer to the Dade Behring shareholders of US $77 per common share. The planned acquisition has a total transaction volume of approximately US$7 billion. Closing is expected in the second quarter of fiscal year 2008, with completion of the merger subject to receipt of regulatory approvals and other customary closing conditions.

Headquartered in Deerfield, IL Dade Behring has operations in 35 countries and serves more than 25,000 customers around the world. The company provides clinical laboratory equipment and integrated solutions for routine chemistry testing, immunodiagnostics (including infectious disease testing), hemostasis testing and microbiology. In fiscal year 2006, Dade Behring realized sales of approximately US $1.7 billion.

"Demographic changes and increasing demand for higher quality healthcare systems represent a constant driver for growth in this sector," stated Peter Loscher, Chief Executive Officer of Siemens AG. “The impact of the Dade Behring acquisition on Siemens EPS (Earnings Per Share) is expected to be accretive from fiscal year 2010."

Erich R. Reinhardt, member of the Managing Board of Siemens AG and president of Siemens Medical Solutions added: "The acquisition of Dade Behring will create significant value for our shareholders. It will strengthen Siemens' position in the highly profitable and high-growth healthcare sector."

For more information: www.siemens.com

Related Content

Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
ViewRay Unveils New Soft Tissue Visualization Technologies for MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | April 30, 2018
ViewRay Inc. announced new magnetic resonance imaging (MRI) technologies under development for its MRIdian Linac...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
News | Image Guided Radiation Therapy (IGRT) | October 10, 2017
Elekta announced that members of the Elekta MR-linac Consortium reported data related to the advancement of the company...
Summit Cancer Center-Boise Treats First Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | August 21, 2017
Accuray Inc. and the Summit Cancer Center-Boise announced that the center is now treating patients with the Radixact...
News | Image Guided Radiation Therapy (IGRT) | July 31, 2017
Elekta’s magnetic resonance radiation therapy (MR/RT) system will be the subject of 21 abstracts at the 59th American...